2196 — Shanghai Fosun Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$52.90bn
- HK$93.26bn
- CNY41.66bn
Annual cashflow statement for Shanghai Fosun Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -15,073 | -18,042 | -19,590 | -19,324 | -19,877 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,949 | 4,218 | 3,414 | 4,477 | 5,213 |
| Capital Expenditures | -4,973 | -5,889 | -5,337 | -4,410 | -4,448 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1,116 | 1,825 | 1,517 | 797 | 2,303 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,857 | -4,064 | -3,819 | -3,613 | -2,146 |
| Financing Cash Flow Items | -727 | 3,055 | -911 | 647 | -1,064 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -831 | 4,428 | -1,336 | -1,003 | -3,244 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -874 | 4,710 | -1,668 | -111 | -353 |